课题基金 / 基金详情

Development of “Covalent Antibody Recruiting Molecules” Tumor Immunotherapeutics

Development of “Covalent Antibody Recruiting Molecules” Tumor Immunotherapeutics
“共价抗体招募分子”肿瘤免疫治疗的开发
批准号：
449819
负责人：
Kapcan Eden
金额：
$1.27万
依托单位：
McMaster University
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2020
资助国家：
加拿大
项目状态：
已结题
起止时间：
2020-12-01 至 2021-12-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=449819&lang=en
关键词：
Antibody Recruiting Molecule Covalent Proximity Inducing Molecules Immune Recognition Of Cancer Immune Synapse Immunotherapy

项目摘要

项目成果

Kapcan Eden的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
A person's immune system is excellent at recognizing and killing diseases, but sometimes diseases are able to hide or block the immune system from killing it. Immunotherapy uses a person's immune system to better recognize and fight diseases such as cance
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Macrophage Covalent Immune Recruiters (mCIRs): A novel synthetic immunotherapeutic enforcing tumor immune recognition
  • 批准号：
    458594
  • 项目类别：
    Studentship Programs
  • 资助金额：
    $7.65万
  • 财政年份：
    2021
  • 负责人：
    Kapcan Eden
  • 依托单位：
    McMaster University